AstraZeneca, YMCA Launch National Cancer Education Partnership
AstraZeneca and YMCA of the USA (Y-USA) have launched a five-year, multimillion-dollar partnership aimed at…
Trending
- AstraZeneca, YMCA Launch National Cancer Education Partnership
- Antares, Novartis Partner on Cancer Drug Discovery
- FDA Approves TRYNGOLZA for Severe Hypertriglyceridemia
- RQ Bio Raises $115 Million for Influenza Antibody Therapy
- EU Approves KEYTRUDA-Padcev for Bladder Cancer
- Merck to Acquire Bio-Techne in $11.3 Billion Deal
- Ionis, Recordati Partner to Expand Zilganersen Access Globally
- Remix Therapeutics to Merge With Passage Bio
- Oura, LillyDirect Partner to Support GLP-1 Patients
- Lilly Completes Centessa Acquisition to Advance Narcolepsy Treatments
Top Headlines
Antares, Novartis Partner on Cancer Drug Discovery
Antares Therapeutics has entered into a strategic collaboration with Novartis to discover, develop, and…
FDA Approves TRYNGOLZA for Severe Hypertriglyceridemia
Ionis Pharmaceuticals has received U.S. Food and Drug Administration (FDA) approval for TRYNGOLZA (olezarsen), a…
RQ Bio Raises $115 Million for Influenza Antibody Therapy
RQ Bio has secured $115 million (£85.5 million) in an oversubscribed Series A financing, providing the…
EU Approves KEYTRUDA-Padcev for Bladder Cancer
Merck has secured European Union approval for a new perioperative treatment regimen combining KEYTRUDA…
Merck to Acquire Bio-Techne in $11.3 Billion Deal
Merck KGaA, Darmstadt, Germany, has announced a definitive agreement to acquire U.S.-based life sciences company…
Featured Event
Clinical Trials
Boehringer Advances Phase III Cancer Precision Medicine Trials
Boehringer Ingelheim has announced the launch of three Phase III clinical trials aimed at advancing precision oncology for patients with some of the…
uniQure Reports Early Promise for Epilepsy Gene Therapy
uniQure has reported encouraging early clinical results from its experimental gene therapy AMT-260, offering new hope for patients living with…
Massive Bio, Optellum Partner to Advance Lung Cancer Trial Access
Massive Bio and Optellum have announced a strategic collaboration designed to connect early lung cancer detection with faster access to clinical…
Phase 3 Success Boosts Prospects for Iza-Bren
SystImmune and Bristol Myers Squibb have reported positive Phase 3 results for izalontamab brengitecan (iza-bren), an investigational bispecific…
GSK Drug Bepirovirsen Shows Promise in Redefining Chronic Hepatitis B Treatment
British pharmaceutical company GSK has reported encouraging late-stage clinical trial results for bepirovirsen, an investigational therapy for chronic…
Regeneron Reports Promising Amyloidosis Trial Results
Regeneron Pharmaceuticals reported encouraging early-stage results from a Phase 1/2 clinical trial evaluating Lynozyfic (linvoseltamab) in patients…
Fast shipping, security and absolute privacy is our main goal Viagra-Buy.com/ savings on their medication from a licensed and certified pharmacy.
The best pharmacy in america Viagra-Buy.com Fast delivery, best prices and for real men
Bayer Partners With Iambic to Accelerate AI Drug Discovery
Bayer has entered into a strategic drug discovery collaboration with Iambic Therapeutics to accelerate the…
XtalPi Lands $400 Million AI Drug Discovery Partnership
XtalPi has entered into a strategic collaboration with a leading international biopharmaceutical company to develop…
Drug Research
Latus Bio Raises $97 Million to Advance Gene Therapies
Latus Bio, Inc. has secured $97 million in Series A financing to accelerate the development of its gene therapy…
UK Streamlines Drug Approvals to Accelerate Patient Access
The Medicines and Healthcare products Regulatory Agency (MHRA) and National Institute for Health and Care…
Novartis Targets Breast Cancer With Novel PI3Kα Inhibitor Deal
Novartis has announced a strategic agreement with Synnovation Therapeutics, LLC to acquire SNV4818, an…
FDA Proposes New Steps to Streamline Biosimilar Drug Development
The U.S. Food and Drug Administration has announced a new regulatory initiative aimed at accelerating the…
Insilico, CMS Partner on AI Drug Discovery Programs
Clinical-stage biotechnology company Insilico Medicine and pharmaceutical commercialization group China Medical…
Manufacturing
Cellares, TScan Partner on Automated TSC-101 Manufacturing
Cellares and TScan Therapeutics have entered into a strategic agreement to evaluate automated clinical…
Fujifilm Expands Stem Cell Manufacturing in Wisconsin
FUJIFILM Cellular Dynamics has inaugurated a new headquarters and induced pluripotent stem cell (iPSC) development…
Piramal, Ajinomoto Partner to Advance ADC Manufacturing Capabilities
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services have announced a strategic collaboration aimed at…
UCB Selects Georgia for Major U.S. Biologics Manufacturing Hub
UCB has announced plans to establish a major new biologics manufacturing facility in Gwinnett County, Georgia,…
LGM Pharma Expands U.S. Manufacturing With $15M Investment
LGM Pharma has announced a $9 million expansion across its U.S. manufacturing network, marking the second phase of…
Terumo BCT, Taiwan Bio Partner on Treg Manufacturing
Terumo Blood and Cell Technologies (Terumo BCT) has entered into a strategic collaboration with Taiwan Bio…
CordenPharma Leases New Lab Facility at Boulder’s Flatiron Park
BioMed Realty has announced that CordenPharma Colorado has signed a long-term lease for a new laboratory facility…
Novo Nordisk Invests €432M to Expand Irish GLP-1 Manufacturing
Pharmaceutical giant Novo Nordisk has announced a €432 million investment to expand its manufacturing facility in…
Diseases
Tenaya and Alnylam Partner to Discover New Genetic Targets for Heart Disease
Clinical-stage biotechnology company Tenaya Therapeutics has announced a new research collaboration with RNA…
AstraZeneca, CSPC Partner on Next-Generation Obesity Therapies
AstraZeneca has strengthened its weight management and metabolic disease pipeline through a new strategic…
China Approves ENHERTU for Second-Line HER2-Positive Gastric Cancer
China’s National Medical Products Administration (NMPA) has approved ENHERTU® (trastuzumab deruxtecan) for the…
InterAx, Alveus Partner to Advance Next-Generation Obesity Therapy
InterAx Biotech Ltd and Alveus Therapeutics Inc. have entered into a strategic research collaboration and licensing…
Sandoz to Acquire Just-Evotec Biologics Facility in Toulouse Under New Term Sheet
Sandoz has signed a non-binding term sheet with Evotec SE to potentially acquire Just–Evotec Biologics EU SAS,…
AstraZeneca and Revna Biosciences Expand Lung Cancer Treatment Access in Ghana
Since announcing their partnership in April 2025, AstraZeneca and Revna Biosciences have made significant strides…
